Search for: "StemCells Inc."
Results 81 - 99
of 99
Sort by Relevance
|
Sort by Date
13 Sep 2011, 9:20 pm
StemCells Inc.'s impending bid for $20 million from the California stem cell agency is taking on greater weight as the company battles to keep its finances flowing. [read post]
22 Mar 2011, 9:53 am
Similarly, StemCells, Inc. has started a stem cell trial considered “landmark event for the field of spinal cord injury research. [read post]
23 Jan 2009, 2:34 am
(StemCells Inc. was founded by Irv Weissman of Stanford, Fred Gage of the Salk Institute and David [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
6 Jun 2008, 6:43 am
A June 6 press release noted: StemCells, Inc. [read post]
16 May 2008, 8:03 am
, (IPRoo), StemCells files second patent lawsuit against Neuralstem in relation to human neural stem cells: (IPBiz), (IP Law360), (Patent Docs), (California Biotech Law Blog), Patent Reform Act removed from Senate calendar: (Peter Zura's 271 Patent Blog), (IAM), (Managing Intellectual Property), (IP Law360), Global Global - General New WIPO Director General: Francis Gurry of Australia: (WIPO), (Managing Intellectual Property), (Innovationpartners), (IAM), (Intellectual… [read post]
14 May 2008, 9:47 pm
By Donald Zuhn -- Earlier this week, we reported on two recently filed patent cases: the first by StemCells, Inc. against Neuralstem, Inc., asserting infringement of U.S. [read post]
12 May 2008, 3:18 am
Forbes (AP) reports on May 12: Clinical-stage biotechnology company StemCells Inc. said Monday [May 12] it filed a second patent lawsuit against Neuralstem in a California federal court, alleging infringement of two patents related to human neural stem cells.There was the discussion of litigate vs. license:"While we are disappointed that Neuralstem chose to escalate matters, we have a duty to our shareholders to protect our good name and the significant value of our… [read post]
11 May 2008, 8:53 pm
StemCells, Inc. et al. v. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US:… [read post]
24 Apr 2008, 3:55 pm
By Donald Zuhn -- Yesterday, StemCells, Inc. announced that the U.S. [read post]
22 Apr 2008, 9:47 pm
By Donald Zuhn -- Last week, StemCells, Inc. announced that the U.S. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
16 Apr 2008, 1:28 am
NeuralStem responded to a press release by StemCells about a re-examination of two StemCells patents:Neuralstem, Inc. today responds to an earlier press release by StemCells, Inc. by stating that StemCells, Inc. has completely mischaracterized the meaning of the US Patent and Trademark Office's most recent action. [read post]
15 Apr 2008, 12:09 pm
See re-exam results on StemCells' patents related to litgation with Neuralstem Inc. [read post]
16 Sep 2007, 9:58 pm
A press release of September 17, 2007 noted: StemCells, Inc. today announced it will begin a patent-reexamination process with the U.S. [read post]
28 Jun 2007, 10:18 am
The AP reported: Biotechnology company StemCells Inc. said Thursday, June 28, 2007, it has agreed to a stay in its patent-dispute lawsuit against Neuralstem Inc. while the U.S. [read post]
